Biweekly irinotecan, oxaliplatin, and infusional 5FU/LV (FOLFOXIRI) versus irinotecan and 5FU/LV (FOLFIRI) as first-line treatment of metastatic colorectal cancer : Results of a randomized phase III trial by the Gruppo Oncologico Nord Ovest (G. O. N. O.)

• FALCONE A

収録刊行物

• Proc ASCO GI, 2006

  Proc ASCO GI, 2006 2006

詳細情報

• CRID: 1573105975217087744
• NII論文ID: 10018784940
• データソース種別:
  • CiNii Articles